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Abstract
Background: The expression of pro-angiogenic cytokines, such as vascular endothelial growth factor (VEGF) and
interleukin-8/CXCL8 (IL-8), plays an important role in tumor growth and metastasis. Low oxygen tension within
poorly-vascularized tumors is thought to be the prime stimulus causing the secretion of VEGF. The expression of
IL-8 by solid tumors is thought to be primarily due to intrinsic influences, such as constitutive activation of nuclear
factor kappa B (NF-κB). However, VEGF expression is responsive to glucose deprivation, suggesting that low
concentrations of nutrients other than oxygen may play a role in triggering the pro-angiogenic phenotype.
Glucose deprivation causes endoplasmic reticulum (ER) stress and alters gene expression through the unfolded
protein response (UPR) signaling pathway. A branch of the UPR, known as the ER overload response (EOR), can
cause NF-κB activation. Thus, we hypothesized that treatments that cause ER stress and deprivation of other
nutrients, such as amino acids, would trigger the expression of angiogenic cytokines by breast cancer cell lines.
Results: We found that glutamine deprivation and treatment with a chemical inducer of ER stress (tunicamycin)
caused a marked induction of the secretion of both VEGF and IL-8 protein by a human breast adenocarcinoma
cell line (TSE cells). Glutamine deprivation, glucose deprivation and several chemical inducers of ER stress
increased VEGF and IL-8 mRNA expression in TSE and other breast cancer cell lines cultured under both
normoxic and hypoxic conditions, though hypoxia generally diminished the effects of glucose deprivation. Of all
amino acids tested, ambient glutamine availability had the largest effect on VEGF and IL-8 mRNA expression. The
induction of VEGF mRNA expression, but not IL-8, was sustained and closely corresponded with the upregulated
expression of the ER stress-responsive genes glucose-regulated protein 78 (GRP78) and growth arrest and DNA
damage inducible gene 153 (GADD153).
Conclusion: These results suggest that nutrient deprivation within the solid tumor microenvironment might
contribute to the activation of a pro-angiogenic phenotype. The angiogenic switch may act to increase blood
supply in response to nutrient deprivation as well as hypoxia.
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Background
It has become apparent that some aspects of malignant
progression are mediated through the effects of the tumor
microenvironment. Environmental conditions affect the
regulation of gene expression by both cancer cells and
stromal cells within the tumor. As tumors grow in size,
they must respond and adapt to a nutrient-limited envi-
ronment. Neoplastic progression includes genetic altera-
tions that allow malignant cells to ignore normal growth
controls. For these cells, growth is limited by the delivery
rate of oxygen and nutrients (such as glucose and amino
acids) and removal rate of waste products (such as CO2
and lactic acid) [1]. As a tumor grows in size, the cancer
cells and the stromal cells that surround them both expe-
rience progressive hypoxia, nutrient starvation and acido-
sis until the tumor microenvironment becomes
deleterious to growth or even toxic [1]. These cells survive
and adapt to this ischemic environment by producing
pro-angiogenic factors to initiate the formation and attrac-
tion of new blood vessels to the tumor [2]. In fact, an
increase in the synthesis of pro-angiogenic factors is a nat-
ural cellular response to an ischemic environment [3].
Many cancer researchers seem to associate ischemia only
with a lack of oxygen delivery. For this reason, much
attention has been devoted to understanding the way that
tumor cells respond and adapt to oxygen limitation.
Tumor hypoxia is a very active research area. We now
know that many genes important to both tumor cell
energy metabolism and angiogenesis are responsive to
hypoxia [4]. By far the most studied hypoxia-responsive
gene is vascular endothelial growth factor A, the original
member of the vascular permeability factor (VPF)/VEGF
family of proteins. Vascular endothelial growth factor A
(hereafter referred to as VEGF) is recognized as the single
most important angiogenic factor [5]. VEGF is a multi-
functional cytokine that is widely expressed by tumor cells
and increases microvascular permeability, induces
endothelial cell migration and division, and promotes
endothelial cell survival [6]. It may also act as an autocrine
survival factor for some cancer cells [7,8]. Plasma levels of
VEGF have prognostic value for several cancers, including
breast cancer [9,10].
In a tumor which has outgrown the existing vasculature,
ischemia results in hypoxia that induces the transcription
of VEGF through a well-defined signaling mechanism [4].
This response to hypoxia stimulates angiogenesis to aug-
ment the existing vasculature and enable the delivery of
greater amounts of oxygen, effectively alleviating the
hypoxic stress. However, the hypoxic response mecha-
nism does not always completely explain the increased
VEGF expression by ischemic tissues. There are several
studies suggesting that hypoxia is not the cause of height-
ened VEGF expression by ischemic tissues or tumors [11-
16].
Several previous studies demonstrated that glucose depri-
vation also induces the expression of VEGF in cultured cell
lines, including HepG2 [17] and Hep3B [11] human
hepatomas, U-937 human monocytic cell line [18], C6 rat
glial tumor cell line [19], and ARPE-19 human retinal pig-
mented epithelial cell line [20]. However, none of these
studies demonstrated a mechanism for this effect. Glucose
deprivation and treatments that cause ER dysfunction lead
to the stressful accumulation of malfolded proteins
within the ER, resulting in an endoplasmic reticulum
stress response (ERSR) and activation of a signal transduc-
tion pathway known as the unfolded protein response
(UPR). The transcription of several ER stress-responsive
genes is highly induced by activation of the UPR, includ-
ing glucose-regulated protein 78 (GRP78) which encodes
the immunoglobin binding protein (BiP), and the growth
arrest and DNA damage inducible gene 153 (GADD153)
which encodes the CEBP-homologous protein
(CHOP10). Because there are several studies demonstrat-
ing the activation of ERSR pathways and the expression of
ER stress-responsive genes in tumor tissue [21-26], we rea-
soned that similar mechanisms could operate in cancer
cells and, if so, then this could contribute to the expres-
sion of VEGF by poorly vascularized tumors.
Secretion of VEGF and IL-8 protein by TSE cells treated with  low glutamine-containing media, tunicamycin, and cobalt  chloride Figure 1
Secretion of VEGF and IL-8 protein by TSE cells 
treated with low glutamine-containing media, tuni-
camycin, and cobalt chloride. Triplicate cultures of con-
fluent TSE cells in six-well plates were incubated with 3 mL 
per well of complete medium containing 4 mM glutamine 
(Q), 0.25 mM glutamine, 5 µg/mL tunicamycin (Tunic) or 100 
µM CoCl2 for 24 hours. A commercial ELISA was used to 
determine the amount of VEGF and IL-8 protein in the 
media. Data represent the mean concentration ± SD.Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
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In addition, we sought to determine if expression of the
CXC cytokine interleukin-8/CXCL8 (IL-8) was also
responsive to nutrient deprivation and ER stress. IL-8 was
first characterized as a neutrophil chemoattractant [27].
Soon after its discovery it was identified as a pro-ang-
iogenic factor, but its role in cancer has only recently been
fully appreciated [28]. Aberrant IL-8 expression has been
documented in several solid tumor types, including breast
[28]. IL-8 seems to function as both a pro-angiogenic and
a pro-metastatic factor [29-35]. Like VEGF, high serum
levels of IL-8 have been shown to be a negative prognostic
indicator in several cancers [36-39]. IL-8 expression is
highly dependent upon activity of nuclear factor kappa B
(NF-κB) [40-42]. In turn, NF-κB can be activated by ER
stress, through a UPR signaling pathway that has been
described as the ER overload response (EOR) [43]. How-
ever, to the best of our knowledge, the effect of nutrient
deprivation and ER stress on IL-8 expression has not yet
been described.
In the present study, a human breast carcinoma cell line
(TSE cells) was used as the model system to test the
hypothesis that VEGF and IL-8 expression by tumor cells
is induced by nutrient deprivation and ER stress. The
expression of VEGF and IL-8 was compared to that of ER
and nutrient stress-responsive genes GRP78 and
GADD153, as well as the hypoxia-responsive gene glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH). The
results show that VEGF expression by TSE cells, as well as
other breast carcinoma cell lines, is highly responsive to
nutrient deprivation and treatments that cause ER stress.
In addition, we present the novel observation that the
expression of IL-8 is responsive to nutrient deprivation
and ER stress. These findings suggest that a low concentra-
tion of nutrients other than oxygen in the tumor microen-
vironment, or any stress that disrupts ER function, has the
potential to increase tumor angiogenesis and metastasis.
Results
Effect of glutamine deprivation, tunicamycin, and cobalt 
chloride on the secretion of VEGF and IL-8 protein by TSE 
cells
To determine if VEGF and IL-8 proteins were secreted by
TSE cells under stress, as induced by glutamine depriva-
tion, tunicamycin (an inhibitor of protein glycosylation
in the ER), or hypoxia (mimicked by CoCl2 [44]), tripli-
cate confluent cultures of the various cell types were
grown in 6-well plates and incubated with 3 mL per well
of complete media containing 4 mM glutamine as a con-
trol, 0.25 mM glutamine, 5 µg/mL tunicamycin, or 100
µM CoCl2 for 24 hours. ELISA was used to determine accu-
mulated VEGF and IL-8 protein contents in the media
(Figure 1). At 4 mM glutamine (the control condition),
TSE cells showed a basal secretion of 5200 pg/mL VEGF
protein. VEGF secretion increased to 6310 pg/mL with
low glutamine conditions, to 10020 pg/mL with tuni-
camycin treatment and to 8340 pg/mL with CoCl2 treat-
ment. Secreted IL-8 protein concentrations were 610 pg/
mL with control conditions, 1310 pg/mL with low
glutamine, 2640 pg/mL with tunicamycin treatment, and
560 pg/mL with CoCl2 treatment. Thus, TSE cells demon-
strated an increased expression and secretion of both
VEGF and IL-8 protein during conditions of glutamine
deprivation and ER stress.
Response of VEGF and IL-8 mRNA expression to ER stress 
and nutrient deprivation under normoxic (20% O2) and 
hypoxic (2% O2) culture conditions
To test the hypothesis that VEGF is an ER stress-responsive
gene with characteristics of expression similar to other ER
stress-responsive genes, and that the mechanism of VEGF
mRNA upregulation through ER stress is distinct from the
well characterized hypoxia response of VEGF, TSE cells
were simultaneously subjected to ER stress or nutrient
deprivation under normoxic and hypoxic conditions. TSE
cells were grown to confluence, rinsed twice with PBS and
fed with either complete control medium, glutamine-free
medium, glucose-free medium, medium containing 5 µg/
mL tunicamycin, medium containing 10 µM A23187 (a
calcium ionophore which releases ER calcium stores),
medium containing 10 µg/mL Brefeldin A (an inhibitor of
ER-to-Golgi vesicle transport) or medium containing
0.1% (v/v) DMSO as a vehicle control. Cells under the
above conditions were treated in duplicate and cultured
either under normoxic (20% O2) or hypoxic (2% O2) con-
ditions for 24h. Total RNA was isolated and Northern
blotting analyses was performed (Figure 2A). Results were
compared to the untreated normoxic control.
This analysis showed that under normoxic conditions
nutrient deprivation and chemical inducers of ER stress
increase VEGF, GRP78 and GADD153 mRNA levels in
similar fashions. VEGF mRNA expression was increased to
the greatest extent (6-fold) in response to glutamine dep-
rivation. VEGF mRNA expression was induced 4-fold in
response to glucose deprivation, 3-fold in response to
tunicamycin treatment, 5-fold in response to A23187 and
4-fold in response to Brefeldin A. GRP78 and GADD153
mRNA expression increased the most following Brefeldin
A treatment (11-fold and 14-fold, respectively). After 24 h
of treatment, IL-8 mRNA expression was increased only in
response to glutamine deprivation, glucose deprivation
and treatment with A23187 (2-fold, 3-fold and 22-fold,
respectively). Under hypoxic conditions, VEGF mRNA
was increased 4-fold in the complete media control sam-
ple compared to the VEGF mRNA level in the normoxic
control sample, confirming VEGF's well-characterized
response to hypoxia. Under hypoxic conditions,
glutamine deprivation, tunicamycin, A23187, and Brefel-
din A all caused further inductions of VEGF mRNA levelsMolecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
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compared to the hypoxic control. Glutamine deprivation
under hypoxic conditions raised VEGF mRNA levels 12-
fold, twice the induction observed when TSE cells were
glutamine starved under normoxic conditions. GAPDH
mRNA was raised slightly under all hypoxic conditions.
Of notice was the fact that glucose deprivation under nor-
moxic conditions induced VEGF and GRP78 mRNAs 4-
fold and 8-fold, respectively, but glucose deprivation
under hypoxic conditions failed to induce expression of
VEGF mRNA at all, and the induction of GRP78 mRNA
fell to 3-fold.
To confirm the observation that hypoxia impairs the
induction of VEGF and GRP78 mRNA normally seen as a
result of glucose deprivation, TSE cells were grown to con-
fluence rinsed twice with PBS and fed with DMEM con-
taining various concentrations of glucose: 0.0, 0.125,
0.25, 0.5, 1, 2, 4, 16 or 25 mM. Dialyzed FBS was used to
supplement the media to prevent serum-derived glucose
from being added. Duplicate samples were then cultured
in hypoxic (2% O2) or normoxic (20% O2) conditions for
24 hours. Total RNA was isolated and Northern blotting
analysis for VEGF, GRP78, GADD153, IL-8 and GAPDH
mRNA was performed (Figure 2B). Samples were com-
pared with the normoxic control (25 mM glucose). Under
normoxic conditions, VEGF and GRP78 mRNAs were
maximally induced at 2 mM glucose to 7-fold and 13-
fold, respectively. In contrast, under hypoxic conditions
inductions of VEGF and GRP78 mRNAs were almost com-
pletely suppressed. Hypoxia suppressed GADD153
mRNA inductions in response to glucose deprivation as
well, by about a multiple of 2 at all concentrations below
2 mM glucose. Under normoxic conditions, GADD153
mRNA was maximally induced 17-fold at 1 mM glucose.
However, at the same concentration of glucose under
hypoxic conditions GADD153 mRNA was induced only
8-fold. Under normoxic conditions, IL-8 mRNA was
greatly induced in a dose-dependent manner in response
to glucose deprivation, being maximally induced 43-fold
at 0.125 mM glucose and similarly induced as glucose
concentrations were reduced to zero. Thus, this dose-
response experiment confirmed that IL-8 mRNA expres-
sion was induced by glucose deprivation. However, inex-
plicably, a much greater level of induction of IL-8
expression by glucose deprivation was obtained in this
experiment than in the previous experiment (Figure 2A).
The induction of IL-8 was greatly reduced under hypoxic
conditions. For example, at 0.125 mM glucose IL-8 mRNA
was only induced by about 4-fold in the presence of
hypoxia. Thus, the effect of glucose deprivation upon the
expression of VEGF, IL-8 and other ER stress-responsive
genes was retained but markedly reduced under hypoxic
conditions.
VEGF, IL-8, GRP78, GADD153 and GAPDH mRNA expres- sion by TSE cells following glutamine deprivation, glucose  deprivation and treatment with chemical inducers of ER  stress under normoxic or hypoxic conditions Figure 2
VEGF, IL-8, GRP78, GADD153 and GAPDH mRNA 
expression by TSE cells following glutamine depriva-
tion, glucose deprivation and treatment with chemi-
cal inducers of ER stress under normoxic or hypoxic 
conditions. (A) Confluent TSE cells were fed with complete 
control medium, glutamine-free medium (-Q), glucose-free 
medium (-Gluc), medium containing 5 µg/mL tunicamycin 
(Tunic), medium containing 10 µM A23187, medium contain-
ing 10 µg/mL Brefeldin A (Bref. A), or medium containing 
0.1% (v/v) DMSO as a vehicle control and cultured under 
either normoxic (20% O2) or hypoxic (2% O2) conditions. 
Total RNA was isolated and Northern blotting analysis per-
formed. (B) Confluent TSE cells were cultured in media con-
taining the indicated concentrations of glucose while under 
normoxic (20% O2) or hypoxic (2% O2) conditions for 24 
hours. Total RNA was isolated and Northern blotting analy-
sis performed.
A
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Expression of VEGF and ER stress-responsive genes was
also examined and compared in TSE, MDA-MB-231,
MDA-MB-453, T47D, and MCF-7 human breast cancer
cell lines subjected to nutrient deprivation and ER stress
for 8 h under normoxic and hypoxic conditions. Conflu-
ent cells were fed with complete control medium,
glutamine-free medium, glucose-free medium, medium
containing 5 µg/mL tunicamycin, 500 nM thapsigargin,
10 µM A23187, 1 mM DTT, 10 µg/mL Brefeldin A, or
medium containing 0.1% (v/v) DMSO as a vehicle con-
trol. The cultures were then placed in 20% O2 or 2% O2-
containing environments for 8 hours. Total RNA was iso-
lated and Northern blot analysis performed (Supplemen-
tal Figure 1 [see Additional File 1]). In response to
glutamine deprivation, VEGF mRNA expression was simi-
larly increased in all cell lines, with the greatest increase in
MDA-MB-231 (2.3-fold). Glucose deprivation increased
VEGF mRNA expression in every cell line tested with the
greatest induction seen in T47D cells (2.9-fold). Tuni-
camycin, thapsigargin, Brefeldin A and A23187 increased
VEGF mRNA expression in all cell lines tested. The MDA-
MB-231 cell line increased the expression of VEGF mRNA
to the greatest extent following treatment with the chemi-
cal inducers of ER stress, tunicamycin (2.5-fold), thapsi-
gargin (2.5-fold), A23187 (5.0-fold) and Brefeldin A (3.2-
fold). Under normoxic conditions, treatment with DTT
induced the expression of VEGF mRNA appreciably only
in the MDA-MB-231 cell line (1.9-fold).
Hypoxia alone increased VEGF mRNA expression in all
cell lines tested, with MDA-MB-453 cell line demonstrat-
ing the greatest induction (3.3-fold). Upon glutamine
deprivation under hypoxic conditions, TSE (3.3-fold),
T47D (3.6-fold) and MCF-7 (2.9-fold) cell lines showed
additionally increased VEGF mRNA expression compared
to the hypoxic control. Under hypoxic conditions, 8 h of
glucose deprivation also additionally upregulated VEGF
mRNA expression compared to the hypoxic control lanes
in TSE (2.9-fold) and MDA-MB-231 (8.8-fold). Glucose
deprivation under hypoxic conditions repressed the
expression of VEGF mRNA compared to the hypoxic con-
trol lanes in the MCF-7, T47D and MDA-MB-453 cancer
cell lines. Most treatments with chemical inducers of ER
stress during hypoxic culture conditions resulted in VEGF
mRNA levels that were higher than those produced by
hypoxia alone in the MCF-7, MDA-MB-231 and MDA-
MB-453 cell line. In T47D cells, only A23187 treatment
resulted in greater (4.0-fold) VEGF mRNA levels than
hypoxia alone.
Expression of IL-8 mRNA was detected only in TSE and
MDA-MB-231 cells, and was markedly increased under
both normoxia and hypoxia by treatment with glutamine-
free medium, glucose-free medium, thapsigargin, A23187
and Brefeldin A. The magnitude of inductions was not
quantifiable because IL-8 mRNA was essentially undetec-
ted in control samples. However, A23187 induced the
greatest IL-8 responses, tunicamycin caused relatively
slight inductions and DTT did not appreciably induce IL-
8 expression in either TSE or MDA-MB-231 cells. Surpris-
ingly, hypoxia did not appreciably induce IL-8 mRNA
expression in any of these breast cell lines. Both tunicamy-
cin and DTT caused dramatic inductions of GRP78 mRNA
expression in each cell. GADD153 expression by these
cells was appreciably responsive to tunicamycin, but not
to DTT treatment.
Response of VEGF, GRP78, GADD153 and IL-8 mRNA 
expression to amino acid deprivation
To determine if VEGF mRNA expression is responsive to
the deprivation of amino acids other than glutamine, TSE
cells were incubated in media lacking one or all of the
amino acids found in modified Eagle's medium (MEM).
TSE cells adapted to MEM were grown to confluence,
rinsed twice and re-fed complete MEM, MEM lacking all
amino acids, or MEM deficient in one of each of the 13
amino acids present in complete MEM and incubated for
12 hours. Dialyzed FBS was used to negate the contribu-
tion of amino acids within the sera. Total RNA was iso-
lated and Northern blotting analyses were performed
(Figure 3B). The amount of VEGF, GRP78, GADD153, IL-
8 and GAPDH mRNA was determined relative to the
amount of 18S rRNA within each sample and mRNA con-
tents were compared to that of control cells in complete
MEM and amino acid-free MEM (Figure 3A). VEGF mRNA
expression was most responsive to glutamine deprivation
(9-fold). Deprivation of other amino acids elicited smaller
inductions. For example, lack of arginine induced VEGF
mRNA 7.6-fold and lack of leucine, lysine and methio-
nine each induced VEGF mRNA approximately 5-fold.
Deprivation of all 13 amino acids induced VEGF mRNA
5.6-fold. GRP78 mRNA was induced to a lesser extent
than VEGF by deprivation of various amino acids.
Glutamine deprivation had the greatest effect on GRP78
mRNA inducing it 2.3-fold. GADD153 mRNA was also
more responsive (3.9-fold) to glutamine deprivation than
to a lack of other amino acids. Total amino acid starvation
resulted in a marked 12.3-fold induction of GADD153. At
this time point, IL-8 expression was only responsive to
glutamine deprivation, with an induction of slightly more
than 2-fold. However, IL-8 mRNA expression was greatly
induced 12-fold by total amino acid starvation. Compari-
son of VEGF with GADD153 mRNA levels yielded a good
correlation (r = 0.79). Comparison of VEGF with GRP78
mRNA levels yielded a decreased correlation (r = 0.63).Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
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The kinetics and sensitivity of VEGF, IL-8, GRP78, 
GADD153, and GAPDH mRNA expression to glutamine 
deprivation
The effects of glutamine deprivation were further charac-
terized by monitoring the expression of VEGF, IL-8 and ER
stress response genes following various durations of com-
plete glutamine starvation and culture conditions with a
range of initial media glutamine concentrations. To exam-
ine the kinetics of inductions for VEGF, GRP78,
GADD153 and IL-8 mRNA expressions, TSE cells were
grown to confluence, rinsed twice and fed with glutamine-
free DMEM supplemented with dFBS. At various times (0,
3, 6, 12, 24, 48 and 72h) total RNA was isolated and
Northern blot analyses for VEGF, GRP78, GADD153, IL-
8, GAPDH and 18S rRNA were performed (Figure 4A).
The amounts of these mRNAs were determined relative to
the amount of 18S rRNA in each sample and compared
with the 0 hour time point control. VEGF mRNA levels
increased rapidly to 3-fold the initial level by 3 hours and
continued to increase, reaching 7-fold at 72 hours of
glutamine deprivation. GRP78 mRNA expression was
induced 1.5-fold at three hours and, 2.5-fold at 6 hours
and maintained about a 2-fold induction for the rest of
the time course. GADD153 mRNA expression was
induced 3.2-fold at 3 hours and maintained roughly the
same level of expression until the 72 hour time point. IL-
8 mRNA expression was promptly induced, reaching 4.7-
fold by 3 hours and a maximal induction of 15-fold at 6
hours. Following a maximal induction at 6 hours, IL-8
mRNA levels decreased to about 4-fold at 24 hours and
maintained this level of expression until the 72 hour time
point. GAPDH levels actually decreased slightly during
glutamine deprivation.
To determine the sensitivity of VEGF and IL-8 expression
to ambient glutamine levels and to compare their expres-
sion with the expression of GRP78, GADD153, GAPDH
mRNA, TSE cells were grown to confluence, rinsed twice
and fed with DMEM containing 0.0, 0.06, 0.125, 0.25,
0.5, 1, 2, or 4 mM glutamine and supplemented with
dFBS. The cells were then cultured for 24 hours, total RNA
was isolated and Northern blotting analysis was per-
formed (Figure 4B). The amount of VEGF, GRP78,
GADD153, IL-8 and GAPDH mRNAs were determined
relative to the amount of 18S rRNA in each sample, and
these values compared with mRNA contents of the 4 mM
glutamine sample. VEGF mRNA expression increased
measurably as initial media glutamine concentrations
were reduced below 2 mM. At the relatively low glutamine
concentration of 250 µM, VEGF mRNA expression was
induced 4.7-fold, and was maintained at a 5-fold level
until glutamine was totally absent. Thus, VEGF expression
was very responsive to a range of glutamine concentra-
tions that compare favorably with the human physiologi-
cal plasma concentration of 0.6 mM. The dose-response
Response of VEGF, IL-8, GRP78, GADD153 and GAPDH  mRNA expression to deprivation of various amino acids Figure 3
Response of VEGF, IL-8, GRP78, GADD153 and 
GAPDH mRNA expression to deprivation of various 
amino acids. TSE cells adapted to MEM were grown to 
confluence, and cultured for 12 hours in MEM without any 
amino acids (-13 a.a.), containing the normal supplement of 
amino acids (+13 a.a.), or in media in which one amino acid at 
a time was deleted as indicated. Total RNA was isolated and 
Northern blotting analysis was performed. Fold increases in 
mRNA levels relative to the sample containing the normal 
supplement of amino acids (+13 a.a.) are shown in (A).
A
BMolecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
Page 7 of 12
(page number not for citation purposes)
of inductions for IL-8, GRP78, and GADD153 mRNAs all
closely resembled that of VEGF mRNA. Comparison of
VEGF and IL-8 mRNA levels gave a correlation coefficient
of r = 0.95. Comparison of VEGF with GADD153 mRNA
levels yielded a correlation coefficient of r = 0.99. Com-
parison of VEGF with GRP78 mRNA levels yielded a cor-
relation coefficient of r = 0.90. Thus, VEGF and IL-8
mRNA expression was induced rapidly in response to
glutamine starvation, was regulated within a physiologi-
cally Relevant range of glutamine concentrations, and cor-
related strongly with other ER stress-responsive genes.
GAPDH mRNA levels did not correlate with those of
VEGF.
Discussion
In 1992 Sweiki and co-workers published a landmark
paper suggesting that expression of VEGF in response to
hypoxia was responsible for neovascularization of gliob-
lastoma multiform [45]. Since then, numerous studies on
the regulation of VEGF by hypoxia have been published.
The relevance of this regulation was highlighted as it was
eventually experimentally demonstrated that rapidly
growing tumors are indeed generally hypoxic, with
regions of very low oxygen tensions [1,46-48]. Thus, there
is now the strong perception that oxygen is the limiting
environmental factor in tumor growth and the major fac-
tor in controlling tumor VEGF expression and
angiogenesis.
However, there are some inconsistencies in the tumor
hypoxia-VEGF theory. For example, Kotch and co-workers
studied the role of HIF-1 in embryonic growth and vascu-
lar development by creating a HIF-1α knockout mouse
[11]. Rather than expressing less VEGF as expected, HIF-
1α-/- embryos expressed even more VEGF than the HIF-
1α+/+ or HIF-1α+/- embryos at the same stage. The authors
surmised that it was glucose deprivation that had caused
up-regulation of VEGF and demonstrated that cultured
cells increased VEGF expression in response to glucose
deprivation. When Tsuzuki and colleagues used HIF-1α-/-
embryonic stem (ES) cells to form tumors, they found that
tumor VEGF expression was diminished. However these
HIF-1α-/- tumors expressed nearly two-thirds the amount
of VEGF that wild-type ES cell tumors expressed [12]. They
concluded that some of this VEGF expression was due to
tumor-infiltrating stromal cells. However, these HIF-1α-/-
tumors expressed significantly more VEGF than tumors
formed from VEGF-/- ES cells. Likewise, when Maxwell and
co-workers used HIF-1β-/- hepatoma cells to form tumors,
they found that the expression of the hypoxia-responsive
gene GLUT3 was abrogated, but the expression of VEGF
was only reduced [13]. In addition, when Griffiths and
colleagues [49] compared the vessel density of HIF-1β-/-
hepatomas to wild type hepatomas they observed "no dif-
ferences in vascularity." These results were not due to
Response of VEGF, IL-8, GRP78, GADD153, and GAPDH  mRNA expression to glutamine starvation over time, and to  various initial concentrations of glutamine in the media Figure 4
Response of VEGF, IL-8, GRP78, GADD153, and 
GAPDH mRNA expression to glutamine starvation 
over time, and to various initial concentrations of 
glutamine in the media. (A) Confluent TSE cells were cul-
tured in glutamine-free medium for the times indicated, or 
(B) in media containing the indicated initial concentrations of 
glutamine for 24 hours. Total RNA was isolated, and North-
ern blotting analysis was performed.
A
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alternative mechanisms of hypoxic induction of VEGF, for
all these studies showed that basal VEGF expression was
negligible in HIF-1α-/- or HIF-1β-/- cells and that VEGF
expression was not induced when these knockouts were
made hypoxic in vitro. Thus, from these studies we con-
clude that although hypoxia plays an important role in
induction of tumor VEGF expression, other factors also
contribute to the control of VEGF expression in vivo.
Raliegh and co-workers tested the role of hypoxia in the
induction of tumor VEGF expression when they compared
the distributions of VEGF protein and the hypoxic marker
pimonidazole in eighteen patients with invasive squa-
mous cell carcinoma of the uterine cervix and head and
neck [14]. These authors stated that, "a quantitative
immunohistochemical comparison of hypoxia and VEGF
protein expression revealed no correlation between these
two factors." Similarly, Fukumura and colleagues studied
the distribution of a hypoxic marker and VEGF expression
in tumors and found no spatial correlation [15]. West and
co-workers used a needle polarographic oxygen electrode
to directly measure oxygen tensions in micro-regions of
38 human cervical cancers prior to tumor removal and
then compare these measurements to regional VEGF and
platelet-derived endothelial growth factor expression
levels measured by immunohistochemistry of tumor sec-
tions [16]. These authors stated that "There was no rela-
tionship between hypoxia and the expression of
angiogenic factors (VEGF, PD-ECGF)." From these data,
we conclude that it is unclear to what extent the mecha-
nism of VEGF induction by hypoxia contributes to tumor
angiogenesis. We propose that environmental factors
other than hypoxia may also contribute to induction of
VEGF expression in the tumor environment.
Tumor cells can also be subjected to glucose and amino
acid deprivation in the tumor microenvironment. We
hypothesized that cancer cells would respond to these
forms of nutrient deprivation by increasing the expression
of pro-angiogenic factors, such as VEGF and IL-8. This
response would allow tumor cells to overcome nutrient
deprivation, as well as hypoxia, by increasing the vascular
supply of nutrients or by metastasizing to a nutrient rich
environment. Using a human breast carcinoma cell line
we found that deprivation of glutamine and treatment
with tunicamycin caused increased secretion of both
VEGF and IL-8. This data suggests that VEGF and IL-8
mRNA continue to be translated and secreted even during
a stress, like tunicamycin treatment, that causes ER stress
and global translation inhibition. Deprivation of glucose,
deprivation of each MEM amino acid except cystine, and
specific chemical inducers of ER stress (tunicamycin,
Brefeldin A, and A23187) markedly increased the expres-
sion of VEGF mRNA. The inductions of VEGF mRNA
expression in response to various durations of glutamine
deprivation and various glutamine concentrations were
well correlated with the inductions of mRNA expression
of ER stress-responsive genes GRP78 and GADD153, sug-
gesting that the induction of VEGF expression was also
due to a transcriptional ERSR. These studies extend previ-
ous findings with other cell types showing that VEGF is
responsive to glucose deprivation [11,17-19]. To the best
of our knowledge, this is only the second study published
that demonstrates that VEGF expression is responsive to
amino acid deprivation, the first being our previous study
with retinal pigmented epithelial cells [20]. In that study
we presented evidence that, similar to hypoxia, glutamine
deprivation increased steady-state VEGF mRNA levels
through both transcriptional activation and mRNA
stabilization.
Treatment with tunicamycin caused greater increases in
secreted VEGF and IL-8 protein accumulation during a 24
hour period than did treatment with 0.25 mM, glutamine-
containing media. In contrast, the level of VEGF and IL-8
mRNAs at the end of 24 hour period were increased more
by glutamine starvation (0 mM) than tunicamycin treat-
ment. In response to tumicamycin, VEGF mRNA
increased by 3-fold and secreted protein accumulation
increased similarly, by approximately 2-fold. In response
to glutamine starvation, IL-8 mRNA increased by 2-fold
and secreted protein accumulation increased similarly, by
slightly over 2-fold due to less severe glutamine depriva-
tion (0.25 mM). Surprisingly, the accumulation of
secreted IL-8 protein occurred with tunicamycin treatment
(Figure 1), while the level of IL-8 mRNA in like-treated
cells shown in Figure 2A is negligible. However, protein
accumulation in the media is expected to be a function of
the integrated temporal mRNA level over the 24-hour
period. As demonstrated for glutamine deprivation, the
temporal nature of the IL-8 response is transient (Figure
4A). Thus the mRNA level at 24 hours should not be
expected to be consistent with the protein accumulation.
We have not determined the temporal nature of the tuni-
camycin response.
VEGF mRNA expression by T47D, MCF-7, MDA-MB-453
and MDA-MB-231 breast carcinoma cell lines was also
increased in response to nutrient deprivation and chemi-
cal inducers of ER stress further suggesting that this is a
general phenomenon that occurs in several, if not all, cell
lines. Only TSE and MDA-MB-231 expressed IL-8 mRNA
levels that were detectable by Northern blotting, and both
cells exhibited induction of IL-8 by nutrient deprivation
and ER stress. However, chemical inducers of ER stress
had quite variable effects on IL-8 expression. It should be
noted that hypoxia did not appreciably induce IL-8
expression in any of the breast cancer cell lines tested. This
is surprising, given that IL-8 has been identified as being
responsive to hypoxia in several tumor cells (for reviewMolecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
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see [50]). The hypoxic induction of IL-8 expression is cer-
tainly cell-specific, for, in a recent study of a series of tran-
sitional cell carcinoma cell lines, Karashima and co-
workers found that some cell lines did and some cell lines
did not exhibit hypoxic induction of IL-8 expression [51].
It is not the case that 2% oxygen is not severe enough
hypoxia to induce IL-8 expression in breast cancer cells,
for we have tested total anoxia and not observed IL-8
induction (data not shown).
To the best of our knowledge this is the first demonstra-
tion that IL-8 expression is responsive to nutrient depriva-
tion and ER stress. In initial experiments, IL-8 mRNA
expression seemed relatively unresponsive to treatments,
with the exception of glucose deprivation, A23187 and
complete amino acid deprivation. However, the response
of IL-8 expression to glutamine deprivation was observed
to be substantial at an earlier time than first examined.
Because IL-8 transcription is very responsive to NF-κB,
which can be stimulated by ER stress [43], it was perhaps
predictable that IL-8 expression was induced by ER stress.
In contrast, amino acid deprivation would not be
expected to activate the UPR or EOR responses, but this
also upregulated IL-8 expression. Just recently, Jiang and
co-workers showed that amino acid deprivation activates
NF-κB, and that this is dependent on phosphorylation of
the eukaryotic initiation factor 2 alpha subunit
(eIF2alpha) by GCN2 (EIF2AK4) [52]. Thus, it is perhaps
also not surprising that amino acid deprivation upregu-
lated IL-8 expression. We have recently found that NF-κB
and AP-1 activity is increased by glutamine deprivation of
TSE cells and that these factors are necessary for induction
of IL-8 expression in response to glutamine deprivation
(E. Bobrovnikova-Marjon, unpublished observations).
However, a macroarray experiment examining the expres-
sion 111 NF-κB-responsive genes found only 13 (includ-
ing IL-8) that were induced by glutamine deprivation (E.
Bobrovnikova-Marjon, unpublished observations). Thus,
not all NF-κB-responsive genes are induced by glutamine
deprivation.
Glutamine deprivation and chemical inducers of ER stress
in conjunction with hypoxia induced the expression of
VEGF to a greater extent than hypoxia alone, suggesting
that hypoxia and an ERSR pathway can increase the
expression of VEGF through distinct mechanisms. In addi-
tion, unlike the expression of ER stress-responsive genes,
the hypoxia-responsive gene GAPDH was not regulated
similarly to VEGF or IL-8. Of interest was the observation
that glucose deprivation and hypoxia independently
increased the expression of VEGF mRNA, but together had
much less effect. A similar phenomena was previously
reported to occur in the C6 glial tumor cell line [53]. It is
possible that hypoxia combined with glucose deprivation
drastically impedes the cell's production of ATP and
inhibits the signal transduction processes or transcription
factor expression needed for these responses. However,
GADD153 mRNA induction was not severely impeded by
the same combination of hypoxia and glucose
deprivation.
Of all the amino acids tested, glutamine deprivation
increased the expression of VEGF and IL-8 by the greatest
extent. Glutamine's function as a nitrogen transporter,
fuel source, and its high concentration in the blood make
it a prime candidate for the study of the effects of nutrient
availability on the expression of VEGF. TSE cells are par-
ticularly dependent upon glutamine for growth and via-
bility, compared to several other human breast carcinoma
cell lines [54]. However, it should be noted that confluent
cultures of TSE cells, like those used in the current study,
do not exhibit appreciable signs of cell death when
glutamine starved for even extended periods (data not
shown). We previously observed that tumor xenographs
formed from TSE cells contained progressively less
glutamine as tumor size increased, demonstrating that
glutamine deprivation can occur in vivo [55].
The main rationale for this study was to test the hypothe-
sis that nutrient deprivation and/or ER stress increases
cancer cell VEGF and IL-8 expression. This is comple-
mented by previous studies suggesting that tumor cells do
experience ER stress in vivo. Gazit and co-workers demon-
strated that the GRP78 promoter was able to drive high
expression levels of green fluorescent protein (GFP) in an
experimental murine fibrosarcoma tumor model [21].
This group went on to use the GRP78 promoter to drive
the tumor-specific expression of HSV-tk as a scheme for
cancer gene therapy [22]. Recently this group produced a
transgenic mouse containing the mouse GRP94 ER stress-
responsive promoter fused to the LacZ reporter gene [23].
This promoter, which contained three ER stress response
DNA elements (ERSRE), was inactive in all normal tissues
examined but was highly active in both spontaneously-
formed and DMBA-induced tumors. Close examinations
of these tumors revealed that LacZ expression was greatest
in both tumor cells and macrophages at the border of
necrotic areas. In addition, several other studies have
demonstrated that genes activated in response to ERSR
pathways are expressed in tumors. These include GRP78
[24,56], GRP78, GRP94 and calnexin [25].
Conclusions
Recently, there have been a great number of discoveries
revealing the role of ERSR in normal development and
pathological processes. We contend that the solid tumor
environment, with its abnormal and insufficient vascula-
ture, is a prime candidate for ERSR activation and we
hypothesize that ERSR can trigger an angiogenic switch in
an effort to improve nutritional delivery. Further experi-Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
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ments are needed to determine if ERSR signal transduc-
tion pathways and transcription factors are involved in
the inductions of VEGF and IL-8 expression by nutrient
deprivation and ER stress. Perhaps more importantly, it
remains to be determined if these mechanisms are active
and contributing to the expression of VEGF and IL-8 and
thus the angiogenic and metastatic phenotype of tumor
cells in vivo.
Methods
Cell Culture
TSE human breast carcinoma cells were provided by Dr.
Simon Powell (Massachusetts General Hospital, Depart-
ment of Radiation Oncology, Boston, MA). T47D, MCF-7,
MDA-MB-453 and MDA-MB-231 breast carcinoma cell
lines were obtained from the American Type Culture Col-
lection (ATCC). Cells were maintained in Dulbecco's
modified Eagle's medium (DMEM, high glucose formula-
tion) supplemented with 4 mM L-glutamine, 10% v/v
fetal bovine serum (FBS), 100 U/mL penicillin, 100 µg/
mL streptomycin, and 0.25 µg/mL amphotericin B. For
Northern blot analyses, cells were plated in 60 cm2 tissue
culture dishes, grown to confluence, fed with fresh
medium one day before being rinsed twice with Dul-
becco's phosphate-buffered saline (DPBS), and re-fed
with fresh media containing drugs or other treatments as
described in the figure legends. For glutamine-deprivation
experiments, glutamine-free medium (DMEM supple-
mented with 10% v/v dialyzed FBS (dFBS) and no
glutamine) containing added glutamine or drugs was
used as described in the figure legends. Experiments
including glucose-starved conditions were performed
with glucose-free DMEM-based medium supplemented
with dFBS as described. Starvation for multiple amino
acids was performed with TSE cells adapted to growth
over several successive passages in modified Eagle's media
(MEM) supplemented as described above for DMEM and
dFBS was used during the experiments. Cells subjected to
hypoxic stress were grown under normoxic culture condi-
tions until treatment, rinsed twice with DPBS, then treated
as described in the legends and placed under hypoxic con-
ditions (37°C, 5% CO2, 2% O2, and 95% humidity). For
the ELISA, cells were plated in 10 cm2 wells of 6-well
plates, grown to confluence, fed with fresh medium one
day before being rinsed twice with DPBS, and re-fed with
fresh medium (3 mL per well), containing drugs or other
treatments, as described in the figure legend.
ELISA assays
ELISA assays were performed with commercial VEGF and
IL-8 ELISA kits (R&D Systems, Minneapolis, MN). Assays
for each sample were performed in duplicate, and read-
ings were compared with standard curves obtained with
human recombinant VEGF165 provided.
RNA isolation and analysis
Total RNA was isolated by the one-step acid-phenol gua-
nidinium procedure [57], with RNA extraction reagent
(RNA-Stat60; TelTest, Friendswood, TX), according to the
manufacturer's protocol, followed by an additional phe-
nol-chloroform extractions. Northern blot analysis was
performed as previously described [58] with cDNAs corre-
sponding to human VEGF (dbEST189750), GRP78
(HAEAC89; ATCC), GADD153 (dbEST298470), IL-8
(dbEST6044688), glyceraldehyde 3-phosphate dehydro-
genase (GAPDH, pHcGAP; ATCC) and rat 18S rRNA used
as templates to generate 32P-labeled probes with a ran-
dom-primer labeling kit (Amersham Pharmacia Biotech,
Piscataway, NJ). The rat 18S rRNA cDNA template was RT-
PCR generated from total rat kidney RNA using R18F2
sense (5'-GCTACCACATCCAAGGAAGGC-3') and R18B1
anti-sense (5'-CCCGTGTTGAGTCAAATTAAGCC-3')
primers.
Statistical analyses
Results of Northern blot analyses were quantified using a
phosphorescence imager (STORM) and accompanying
software (ImageQuant; Molecular Dynamics, Sunnyvale,
CA). Integrated band intensities for the probed mRNAs
were divided by those for 18S rRNA to obtain normalized
values of mRNA levels in each sample. Fold increases were
obtained by dividing normalized integrated band intensi-
ties for experimental samples by that of a control
(untreated, time 0, or complete media) sample. ELISA
assays were performed in duplicate, and readings were
compared with standard curves obtained with human
recombinant VEGF165 provided. Means and standard devi-
ations of concentrations in triplicate samples were com-
pared by Student's t-test.
Competing interests
None declared.
Authors' contributions
PLM performed all experiments with the assistance of
EVB-M and wrote the initial draft of the manuscript. EVB-
M assisted with tissue culture, Northern blotting and with
composition of figures and text. SFA planned and super-
vised the study and wrote the final draft of the manuscript.
Additional material
Additional File 1Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
Page 11 of 12
(page number not for citation purposes)
Acknowledgements
The authors wish to acknowledge Dr. Robert Glew, Professor of Biochem-
istry and Molecular Biology, UNM-SOM for his invaluable assistance in the 
writing of this manuscript. This work was supported by: Grant CA077272 
from the National Cancer Institute (SFA), Grant BC023698 from the 
Department of Defense Breast Cancer Research Program (SFA), University 
of New Mexico School of Medicine Research Allocation Grant (SFA), and 
the University of New Mexico Department of Biochemistry and Molecular 
Biology Faculty Predoctoral Fellowship (PLM). PLM was supported by 
Grant GM6020 from the National Institute of General Medical Sciences' 
Minority Biomedical Research Support Program/Initiative for Minority Stu-
dent Development Program. This work represents partial fulfillment of the 
requirements for Masters of Science Degree in Biomedical Sciences by 
PLM.
References
1. Vaupel P, Hockel M: Blood supply, oxygenation status and met-
abolic micromilieu of breast cancers: characterization and
therapeutic relevance.  International Journal of Oncology. 2000,
17:869-879.
2. Giordano FJ, Johnson RS: Angiogenesis: the role of the microen-
vironment in flipping the switch. Current Opinion in Genetics &
Development. 2001, 11:35-40.
3. Marti HH, Risau W: Angiogenesis in ischemic disease. Thrombosis
& Haemostasis 1999, 82:44-52.
4. Harris AL: Hypoxia--a key regulatory factor in tumour
growth. Nature Reviews. Cancer. 2002, 2:38-47.
5. Ferrara N: Role of vascular endothelial growth factor in regu-
lation of physiological angiogenesis. American Journal of Physiology
- Cell Physiology 2001, 280:C1358-66.
6. Ferrara N: Molecular and biological properties of vascular
endothelial growth factor.  Journal of Molecular Medicine 1999,
77:527-543.
7. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND, Kim KW: Hypoxia-
induced VEGF enhances tumor survivability via suppression
of serum deprivation-induced apoptosis.  Oncogene 2000,
19:4621-4631.
8. Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ:
Vascular endothelial growth factor (VEGF) upregulates
BCL-2 and inhibits apoptosis in human and murine mam-
mary adenocarcinoma cells.  British Journal of Cancer 2001,
85:273-278.
9. Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-Van
Gelder ME, Geurts-Moespot A, van Der Kwast TH, Sweep CG, Klijn
JG: High tumor levels of vascular endothelial growth factor
predict poor response to systemic therapy in advanced
breast cancer. Cancer Research 2001, 61:5407-5414.
10. Gasparini G: Prognostic value of vascular endothelial growth
factor in breast cancer. Oncologist 2000, 5:37-44.
11. Kotch LE, Iyer NV, Laughner E, Semenza GL: Defective vasculari-
zation of HIF-1alpha-null embryos is not associated with
VEGF deficiency but with mesenchymal cell death. Develop-
mental Biology 1999, 209:254-267.
12. Tsuzuki Y, Fukumura D, Oosthuyse B, Koike C, Carmeliet P, Jain RK:
Vascular endothelial growth factor (VEGF) modulation by
targeting hypoxia-inducible factor-1alpha--> hypoxia
response element--> VEGF cascade differentially regulates
vascular response and growth rate in tumors. Cancer Research
2000, 60:6248-6252.
13. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford
IJ, Hankinson O, Pugh CW, Ratcliffe PJ: Hypoxia-inducible factor-
1 modulates gene expression in solid tumors and influences
both angiogenesis and tumor growth. Proceedings of the National
Academy of Sciences of the United States of America 1997,
94:8104-8109.
14. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler
MC, Fowler W. C., Jr., Novotny DB, Varia MA: Hypoxia and vascu-
lar endothelial growth factor expression in human squamous
cell carcinomas using pimonidazole as a hypoxia marker.
Cancer Research 1998, 58:3765-3768.
15. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M,
Nielsen G, Taksir T, Jain RK, Seed B: Tumor induction of VEGF
promoter activity in stromal cells. Cell. 1998, 94:715-725.
16. West CM, Cooper RA, Loncaster JA, Wilks DP, Bromley M: Tumor
vascularity: a histological measure of angiogenesis and
hypoxia. Cancer Research 2001, 61:2907-2910.
17. Park SH, Kim KW, Lee YS, Baek JH, Kim MS, Lee YM, Lee MS, Kim
YJ: Hypoglycemia-induced VEGF expression is mediated by
intracellular Ca2+ and protein kinase C signaling pathway in
HepG2 human hepatoblastoma cells.  International Journal of
Molecular Medicine 2001, 7:91-96.
18. Satake S, Kuzuya M, Miura H, Asai T, Ramos MA, Muraguchi M, Ohm-
oto Y, Iguchi A: Up-regulation of vascular endothelial growth
factor in response to glucose deprivation. Biology of the Cell
1998, 90:161-168.
19. Stein I, Neeman M, Shweiki D, Itin A, Keshet E: Stabilization of vas-
cular endothelial growth factor mRNA by hypoxia and
hypoglycemia and coregulation with other ischemia-induced
genes. Molecular & Cellular Biology 1995, 15:5363-5368.
20. Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL: Response of
VEGF expression to amino acid deprivation and inducers of
endoplasmic reticulum stress. Investigative Ophthalmology & Visual
Science. 2002, 43:2791-2798.
21. Gazit G, Kane SE, Nichols P, Lee AS: Use of the stress-inducible
grp78/BiP promoter in targeting high level gene expression
in fibrosarcoma in vivo. Cancer Research 1995, 55:1660-1663.
22. Gazit G, Hung G, Chen X, Anderson WF, Lee AS: Use of the glu-
cose starvation-inducible glucose-regulated protein 78 pro-
moter in suicide gene therapy of murine fibrosarcoma.
Cancer Research 1999, 59:3100-3106.
23. Reddy RK, Lu J, Lee AS: The endoplasmic reticulum chaperone
glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic
properties is a novel proteolytic target of calpain during
etoposide-induced apoptosis. Journal of Biological Chemistry. 1999,
274:28476-28483.
24. Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN,
Schwartz AM, Kennedy KA, Patierno SR: Overexpression of the
glucose-regulated stress gene GRP78 in malignant but not
benign human breast lesions. Breast Cancer Research & Treatment
2000, 59:15-26.
25. Chen X, Ding Y, Liu CG, Mikhail S, Yang CS: Overexpression of
glucose-regulated protein 94 (Grp94) in esophageal adeno-
carcinomas of a rat surgical model and humans. Carcinogenesis
2002, 23:123-130.
26. Korabiowska M, Cordon-Cardo C, Betke H, Schlott T, Kotthaus M,
Stachura J, Brinck U: GADD153 is an independent prognostic
factor in melanoma: immunohistochemical and molecular
genetic analysis. Histology & Histopathology 2002, 17:805-811.
27. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E,
Oppenheim JJ, Leonard EJ: Purification of a human monocyte-
derived neutrophil chemotactic factor that has peptide
sequence similarity to other host defense cytokines. Proceed-
ings of the National Assembly of Science USA 1987, 84:9233-9237.
28. Xie K: Interleukin-8 and human cancer biology.  Cytokine &
Growth Factor Reviews 2001, 12:375-391.
29. De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE,
Manivel JC, Furcht LT: A potential role for interleukin-8 in the
Supplemental Data Figure S1. VEGF, IL-8, GRP78, GADD153, and 
GAPDH mRNA expression in MDA-MB-453, T47D, MDA-MB-231, 
TSE, and MCF-7 cells following 8 h of glutamine deprivation, glucose 
deprivation or treatments with chemical inducers of ER stress under 
normoxic and hypoxic conditions. Confluent cells were fed with complete 
control medium (4Q), glutamine-free medium (-Q), glucose-free 
medium (-Glucose), medium containing 5 µg/mL tunicamycin, 500 nm 
Thapsigargin, 10 µM A23187, 1 mM DTT, 10 µg/mL Brefeldin A, or 
medium containing 0.1% (v/v) DMSO as a vehicle control and cultured 
under either normoxic (20% O2) or hypoxic (2% O2) conditions for 8 
hours. Total RNA was isolated and Northern blotting analysis performed.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
4598-3-4-S1.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Molecular Cancer 2004, 3 http://www.molecular-cancer.com/content/3/1/4
Page 12 of 12
(page number not for citation purposes)
metastatic phenotype of breast carcinoma cells. American Jour-
nal of Pathology 2001, 158:639-646.
3 0 . L i  A ,  D u b e y  S ,  V a r n e y  M L ,  D a v e  B J ,  S i n g h  R K :  IL-8 directly
enhanced endothelial cell survival, proliferation, and matrix
metalloproteinases production and regulated angiogenesis.
Journal of Immunology. 2003, 170:3369-3376.
31. Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM,
Bar-Eli M: Fully humanized neutralizing antibodies to inter-
leukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and
metastasis of human melanoma. American Journal of Pathology.
2002, 161:125-134.
32. Masuya D, Huang C, Liu D, Kameyama K, Hayashi E, Yamauchi A,
Kobayashi S, Haba R, Yokomise H: The intratumoral expression
of vascular endothelial growth factor and interleukin-8 asso-
ciated with angiogenesis in nonsmall cell lung carcinoma
patients. Cancer 2001, 92:2628-2638.
33. Kim SJ, Uehara H, Karashima T, McCarty M, Shih N, Fidler IJ: Expres-
sion of interleukin-8 correlates with angiogenesis, tumori-
genicity, and metastasis of human prostate cancer cells
implanted orthotopically in nude mice. Neoplasia (New York)
2001, 3:33-42.
34. Rofstad EK, Halsor EF: Vascular endothelial growth factor,
interleukin 8, platelet-derived endothelial cell growth factor,
and basic fibroblast growth factor promote angiogenesis and
metastasis in human melanoma xenografts. Cancer Research
2000, 60:4932-4938.
35. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S,
Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP: Interleukin 8
expression regulates tumorigenicity and metastases in
androgen-independent prostate cancer. Clinical Cancer Research
2000, 6:2104-2119.
36. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T: Clinical implications of
expression of interleukin 8 related to angiogenesis in uterine
cervical cancers. Cancer Research. 2000, 60:2632-2635.
37. Nurnberg W, Tobias D, Otto F, Henz BM, Schadendorf D: Expres-
sion of interleukin-8 detected by in situ hybridization corre-
lates with worse prognosis in primary cutaneous
melanoma.[comment]. Journal of Pathology. 1999, 189:546-551.
38. Retzlaff S, Padro T, Koch P, Oelmann E, Lugering N, Mesters RM, Ber-
del WE: Interleukin 8 and Flt3 ligand as markers of advanced
disease in primary gastrointestinal non-Hodgkin's
lymphoma. Oncology Reports. 2002, 9:525-527.
39. Orditura M, De Vita F, Catalano G, Infusino S, Lieto E, Martinelli E,
Morgillo F, Castellano P, Pignatelli C, Galizia G: Elevated serum
levels of interleukin-8 in advanced non-small cell lung cancer
patients: relationship with prognosis.  Journal of Interferon &
Cytokine Research. 2002, 22:1129-1135.
40. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple
control of interleukin-8 gene expression. Journal of Leukocyte
Biology. 2002, 72:847-855.
41. Takaya H, Andoh A, Shimada M, Hata K, Fujiyama Y, Bamba T: The
expression of chemokine genes correlates with nuclear fac-
tor-kappaB activation in human pancreatic cancer cell lines.
Pancreas 2000, 21:32-40.
42. Huang S, DeGuzman A, Bucana CD, Fidler IJ: Level of interleukin-
8 expression by metastatic human melanoma cells directly
correlates with constitutive NF-kappaB activity. Cytokines, Cel-
lular & Molecular Therapy 2000, 6:9-17.
43. Pahl HL, Baeuerle PA: The ER-overload response: activation of
NF-kappa B. Trends in Biochemical Sciences 1997, 22:63-67.
44. Yuan Y, Beitner-Johnson D, Millhorn DE: Hypoxia-inducible factor
2alpha binds to cobalt in vitro. Biochemical & Biophysical Research
Communications 2001, 288:849-854.
45. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth
factor induced by hypoxia may mediate hypoxia-initiated
angiogenesis. Nature 1992, 359:843-845.
46. Vukovic V, Haugland HK, Nicklee T, Morrison AJ, Hedley DW:
Hypoxia-inducible factor-1alpha is an intrinsic marker for
hypoxia in cervical cancer xenografts. Cancer Research. 2001,
61:7394-7398.
47. Richard DE, Berra E, Pouyssegur J: Angiogenesis: how a tumor
adapts to hypoxia.  Biochemical & Biophysical Research
Communications 1999, 266:718-722.
48. Brown JM, Giaccia AJ: The unique physiology of solid tumors:
opportunities (and problems) for cancer therapy.  Cancer
Research. 1998, 58:1408-1416.
49. Griffiths JR, McSheehy PM, Robinson SP, Troy H, Chung YL, Leek RD,
Williams KJ, Stratford IJ, Harris AL, Stubbs M: Metabolic changes
detected by in vivo magnetic resonance studies of HEPA-1
wild-type tumors and tumors deficient in hypoxia-inducible
factor-1beta (HIF-1beta): evidence of an anabolic role for
the HIF-1 pathway. Cancer Research. 2002, 62:688-695.
50. Shi Q, Xiong Q, Le X, Xie K: Regulation of interleukin-8 expres-
sion by tumor-associated stress factors. Journal of Interferon &
Cytokine Research 2001, 21:553-566.
51. Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McCo-
nkey DJ, Dinney CP: Nuclear factor-kappaB mediates angio-
genesis and metastasis of human bladder cancer through the
regulation of interleukin-8.  Clinical Cancer Research 2003,
9:2786-2797.
52. Jiang HY, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, Cavener
DR, Wek RC: Phosphorylation of the alpha subunit of eukary-
otic initiation factor 2 is required for activation of NF-kap-
paB in response to diverse cellular stresses. Molecular and cell
Biology 2003, 23:5651-5663.
53. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular
endothelial growth factor expression by hypoxia and by glu-
cose deficiency in multicell spheroids: implications for tumor
angiogenesis. Proceedings of the National Academy of Sciences of the
United States of America 1995, 92:768-772.
54. Collins CL, Wasa M, Souba WW, Abcouwer SF: Determinants of
glutamine dependence and utilization by normal and tumor-
derived breast cell lines.  Journal of Cell Physiology 1998,
176:166-178.
55. Collins CL, Wasa M, Souba WW, Abcouwer SF: Regulation of
glutamine synthetase in human breast carcinoma cells and
experimental tumors. Surgery 1997, 122:451-63; discussion 463-4.
56. Song MS, Park YK, Lee JH, Park K: Induction of glucose-regulated
protein 78 by chronic hypoxia in human gastric tumor cells
through a protein kinase C-epsilon/ERK/AP-1 signaling
cascade. Cancer Research 2001, 61:8322-8330.
57. Chomcynski P, Sacchi N: Single-step method of RNA isolation
by acid guanidinium thiocyanate-phenol-chloroform
extraction. Anal. Biochem. 1987, 162:156-159.
58. Abcouwer SF, Schwarz C, Meguid RA: Glutamine deprivation
induces the expression of GADD45 and GADD153 primarily
by mRNA stabilization. J. Biol. Chem. 1999, 274:28645-28651.